Observational Study
Copyright ©The Author(s) 2023.
World J Hepatol. Jan 27, 2023; 15(1): 89-106
Published online Jan 27, 2023. doi: 10.4254/wjh.v15.i1.89
Figure 2
Figure 2 Incidence of liver disease in Wales 1999-2019. A: The incidence of liver disease by aetiology recorded by routine coding following inpatient and day case admission and on death certification in Wales between 1999 and 2019; B: The European Age Standardised Rate of the incidence of liver disease in Wales between 2001 and 2019; C: The incidence of index diagnosis of liver disease stage (cirrhosis, portal hypertension, decompensation and liver cancer) caused by liver diseases of all aetiologies in Wales; D: All cause mortality in individuals with a preceding liver disease diagnosis in Wales 1999-2019. ArLD: Alcohol related liver disease; NALFD: Non-alcoholic fatty liver disease; HCV: Hepatitis C virus; HBV: Hepatitis B virus; A1AT: Alpha 1 antitrypsin deficiency.